Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

3.83
-0.1000-2.54%
Post-market: 3.80-0.0300-0.78%19:55 EDT
Volume:892.40K
Turnover:3.45M
Market Cap:123.31M
PE:-2.64
High:4.12
Open:3.98
Low:3.78
Close:3.93
Loading ...
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2024

Correspondence

Form CORRESP - Correspondence
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities